Sign In
Buy RANI
$0.774
-0.0462 (-5.63%)
At Close: Jul 31, 2026
Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update
04:05pm, Friday, 11'th Aug 2023
- Expansion of partnership with Celltrion for development of RT-105 to complement existing partnership for RT-111 - Appointment of Kate McKinley as Chief Business Officer - Presentation of three abstr
Rani Therapeutics to Participate in August Investor Conferences
04:05pm, Friday, 04'th Aug 2023
SAN JOSE, Calif., Aug. 04, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the ora
Rani Therapeutics: Novel Drug Delivery System, Under-Covered And Early Stage
05:33pm, Friday, 05'th May 2023
Rani Therapeutics Holdings, Inc. has an exciting oral drug delivery system for biologics. It has shown excellent early data in trials.
Pluto Biosciences Raises $3.7M to Revolutionize Biological Data Interpretation and Accelerate Life Sciences Discoveries
12:30pm, Tuesday, 02'nd May 2023
DENVER--(BUSINESS WIRE)--Pluto Biosciences, a cutting-edge life sciences software-as-a-service (SaaS) platform, announced today the closing of a $3.7 million seed round led by Silverton Partners in Au
CyberGRX Announces Winners of the Inaugural Cyber Risk Nation Awards
09:00am, Wednesday, 26'th Apr 2023
DENVER--(BUSINESS WIRE)--CyberGRX, provider of the world’s first and largest global risk exchange, today announced the winners of the inaugural Cyber Risk Nation Awards. These awards honor leaders w
Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference
08:00am, Tuesday, 11'th Apr 2023
SAN JOSE, Calif., April 11, 2023 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the or
Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates
04:05pm, Thursday, 16'th Mar 2023
Management to host conference call on Wednesday, March 22 at 4:30 p.m. ET Management to host conference call on Wednesday, March 22 at 4:30 p.m. ET
Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates
06:48pm, Thursday, 10'th Nov 2022
Rani Therapeutics Holdings, Inc. (RANI) delivered earnings and revenue surprises of 0% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for th
Rani Therapeutics to Present at the Stifel Healthcare Conference
04:05pm, Wednesday, 09'th Nov 2022
SAN JOSE, Calif., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the ora
Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference
04:05pm, Tuesday, 06'th Sep 2022
SAN JOSE, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the or
Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue Estimates
06:48pm, Wednesday, 10'th Aug 2022
Rani Therapeutics Holdings, Inc. (RANI) delivered earnings and revenue surprises of -10.71% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for th
Rani Therapeutics to Present at Upcoming Investor Conferences
04:05pm, Tuesday, 03'rd May 2022
SAN JOSE, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the oral
Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference
04:05pm, Thursday, 07'th Apr 2022
SAN JOSE, Calif., April 07, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the or
Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript
09:18pm, Tuesday, 29'th Mar 2022
Rani Therapeutics Holdings, Inc. (RANI) Talat Imran on Q4 2021 Results - Earnings Call Transcript
Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022
08:38pm, Wednesday, 23'rd Mar 2022
SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical stage biotherapeutics company focused on the or
